Cnbx Pharmaceuticals Inc. (CNBX) SEC Filings — 2025
5 SEC filings for Cnbx Pharmaceuticals Inc. (CNBX) in 2025.
Filings
- CNBX Pivots to Cannabinoid Cancer Drugs, Eyes 2026 Clinical Trials — 10-K · Dec 1, 2025
- CNBX Pharmaceuticals Reports No Revenue, Minimal Net Loss in Q3 — 10-Q · Jul 14, 2025
- CNBX Pharmaceuticals Inc. Files Q2 2025 10-Q — 10-Q · Apr 14, 2025
- CNBX Pharmaceuticals Inc. Files 8-K for Material Agreement — 8-K · Jan 30, 2025
- CNBX Pharmaceuticals Files Q1 2025 10-Q — 10-Q · Jan 13, 2025